Christine Burbank Nelson

Experience

• 

  Mérieux NutriSciences - North America

  Nov 2000 - Apr 2001

  Microbiologist

  Pathogen testing using PCR; set up samples, analyzed and logged results; adhered to FDA and USDA methods.

• 

  Wyeth Pharmaceuticals

  Apr 2001 - Oct 2001

  Research Associate

  In GLP environment, implemented RSV nasal spray plume studies and authored associated SOP for syringe actuator. Cultured cell lines and performed viral potency, ELISA assays, spray characterization and moisture analysis studies.

• 

  Covance

  Oct 2001 - May 2020

  Responsible for project scheduling, integrated opportunities, production process, and data analysis through coordination with domestic/international sites, reviewing deliverables requirements and determining timelines. Supervised, trained, evaluated and developed a team of 7-10 associates performing monoclonal antibody generation and large scale production. Generated monoclonal antibodies, cultured and maintained cell lines for in-vivo/in-vitro studies, performed ELISA screening and purification.

  • Senior Scientist

    Jan 2005 - May 2020

  • Immunology Research Associate III

    Oct 2001 - Jan 2005
• 

  Labcorp Drug Development

  May 2020 - Jan 2022

  Manager I, Laboratory

  Lead and direct the scientific team overall in the assay, antibody and purification laboratories in a multi-matrix environment. Daily oversight and management of multiple client research projects to ensure protocols, data and product delivery deadlines, milestones and cost estimates are adhered to. Develop and deliver new testing methods to support vaccine services. Connect and maintain remote and face to face cross functional teams resulting in higher productivity and engagement.

• 

  Xencor

  Mar 2022 - Jan 2024

  Senior Scientific Manager - Critical Reagents

  Leading the scientific and business processes for supply chain management, manufacture, characterization, and control of protein and cell bank reagents for bioanalytical methods for development pipeline, including those supporting pharmacokinetic, immunogenicity, biomarker, and potency endpoints.